New Products

Neova Dual Matrix Now Available

NEOVA Dual Matrix, a refining facial treatment with patented retinol technology and liposome encapsulated DNA repair enzymes, is now available. Pairing the power of retinol with DNA repair enzymes, the serum delivers a dual action reduction in the appearance of fine lines and wrinkles, while visibly improving skin tone, texture, and clarity, and fighting hormone-related acne, with visible results within 14 days without the irritation seen by retinol-based prescription strength products. Neova.com

Obagi Sun Shield Mineral Broad Spectrum SPF 50

Obagi introduced its new Sun Shield Mineral Broad Spectrum SPF 50, which provides UVA and UVB sun protection with a light-stable 4.7% zinc oxide plus 4.9% titanium dioxide formulation. The product provides up to 40 minutes of water-resistant protection. It is formulated with a unique blend of ingredients and is lightweight, oil free, and appropriate for all skin types and designed for sensitive skin. It’s non-comedogenic, non-irritating, and non-sensitizing. Obagi.com

New Strivectin Products

StriVectin recently launched Advanced Retinol Intensive Night Moisturizer and Advanced Retinol Pore Refiner. The intensive overnight moisturizer supports the four essential building blocks of healthy skin appearance: proteins, micronutrients, water, and lipids. Retinol helps improve cell turnover, visibly enhancing skin firmness and elasticity and diminishing the look of lines and wrinkles. Patented NIA-114 TM technology nourishes the moisture barrier to provide visible age fighting efficacy and limit the sensitivity common to retinol. Formulated with Copper Tripeptides, plant lipids, and hyaluronic acid that help lock in moisture and defend against damage caused by environmental aggressors, it is formulated to help restore skin to its healthiest state during sleep for a more refined, youthful looking appearance. The lightweight pore minimizing lotion with Retinol that’s scientifically proven to help improve cell turnover and deliver instant and long-term visible pore reduction. Patented NIA-114TM technology nourishes the moisture barrier to provide visible age fighting efficacy and limit the sensitivity common to retinol. The pore refiner is scientifically proven to refine the appearance of enlarged pores, purify, tighten, and reduce the size of pores and absorb excess oil to control shine throughout the day while hydrating the skin and smoothing the skin’s texture. StriVectin.com

Therapeutic Focus: Lasers

Data Demonstrate Efficacy of a PFD Patch in Tattoo Removal

Results of a clinical study evaluating the potential role of a Perfluorodecalin (PFD)-infused gel patch in laser-assisted tattoo removal were presented at the American Society for Dermatologic Surgery (ASDS) Annual Meeting. The study evaluated the DeScribe Transparent PFD Patch as an accessory to laser tattoo removal procedures to increase patient satisfaction by cutting down on the number of treatments needed to fully remove an unwanted tattoo. Use of the patch conclusively demonstrated faster clearance with higher subject satisfaction than conventional single pass treatment. Study participants presented with blue or black tattoos and were treated with a standard Q-switched Alexandrite laser at maximum tolerable fluence. A single laser pass was delivered on the control side without the DeScribe patch, yet four passes were routinely achievable if the PFD Patch was used. The study found that the majority of subjects showed accelerated clearing on the patch side of the tattoo, and preferred the patch-treated side versus the control. Additionally, no adverse events were observed.

Novel Dual-Wavelength, Nd:YAG, Picosecond-domain Laser Safely and Effectively Removes Multicolor Tattoos

Research published in the September 2015 issue of Lasers in Surgery and Medicine (LSM), evaluated 21 tattooed subjects between the ages of 19-55 who had a total of 31 tattoos treated using a commercial picosecond-domain laser to determine the effectiveness verses the standard Q-switch laser. The average clearance overall as evaluated by blinded observers evaluating randomized digital photographs was 79 ± 0.9% (mean ± sem) after an average of 6.5 treatments. Of the 31 tattoos completing treatment, six had evidence of mild hyper- or hypo-pigmentation by evaluation of photographs. The researcher concluded that the 350 picosecond, 532 nm, and 450 picosecond 1,064 nm Nd:YAG laser is safe and effective for removing decorative tattoos.

Syneron: PicoWay Resolve and CO2RE News

Syneron Medical Ltd. introduced the PicoWay Resolve™, a dual wavelength fractional modality for the PicoWay picosecond laser. The launch of the new Resolve fractional picosecond modality, which features both 532nm and 1064nm wavelengths, comes less than a year after the November 2014 launch of the PicoWay platform.

The FDA has granted numerous additional indications for use of Syneron Medical Ltd.’s CO2RE CO2 device. This clearance, including more than 90 specific indications in total, significantly expands the business opportunity for CO2RE users for high patient demand treatments. Among others, the new indications for use include wrinkles, scars, and a wide range of dermatology and plastic surgery indications.

Lumenis Acquires Pollogen

Lumenis Ltd. completed its acquisition of Pollogen Ltd., an Israeli-based medical aesthetic company that develops and manufactures advanced technologies with full-lines of clinically proven, non-invasive, anti-aging facial and body contouring treatment platforms for a spectrum of aesthetic applications. The product platforms include OxyGeneo®, VoluDerm™, Hybrid Energy™, TriPollar®, TriLipo® and TriFractional™. n